
Marksans Pharma Limited has informed the Exchange regarding a press release dated December 09, 2021, titled "Marksans Pharma Limited announces UK MHRA approval for Loperamide 2mg Hard Capsules.".
Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated December 09, 2021, titled "Marksans Pharma Limited announces UK MHRA approval for Loperamide 2mg Hard Capsules.".
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma